Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-23-009663
Filing Date
2023-07-25
Accepted
2023-07-25 16:03:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ndra_defa14a.htm DEFA14A 20993
  Complete submission text file 0001654954-23-009663.txt   22083
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37969 | Film No.: 231108565
SIC: 3845 Electromedical & Electrotherapeutic Apparatus